原著論文
1.

Hayashi M, Yoshikawa T, Mizusawa J, Hato S, Iwasaki Y, Sasako M, Kawachi Y, Iishi H,Choda Y, Boku N, Terashima M. Prognostic Impact of Post-operative Infectious
Complications in Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy: Posthoc Analysis of a Randomized Controlled Trial, JCOG0501. J Gastrointest Cancer. 2024
May 4. doi: 10.1007/s12029-024-01061-3. Online ahead of print.

2.

Hayashi M, Makoto Abe, Fujita T, Matsushita H. Prognostic effect of categorized tumor
deposits in gastric cancer: A single-center retrospective study. Surgery. 2024
Feb;175(2):373-379. doi: 10.1016/j.surg.2023.09.039. Epub 2023 Nov 7.

3.

Hayashi M, Fujita T, Matsushita H. Prognostic Relevance of Recurrent Sites of Gastric
Cancer Treated with Curative Resection: A single center retrospective study. Journal ofGastric Cancer. January 2024. doi: 10.5230/jgc.2024.24.e2316.
4.

Hayashi M, Fujita T, Matsushita H. Clinical Complete Response of Recurrent Gastric
Cancer after a Third-Line CPT-11 Chemotherapy. Keio J Med. 2023 Jun 25;72(2):6064. doi: 10.2302/kjm.2022-0004-CR. Epub 2023 Feb 4.

5.

Hayashi M, Fujita T, Matsushita H. Evaluating the optimal treatment strategy for early
and advanced remnant gastric cancer. ANZ J Surg. 2022 Nov;92(11):2907-2914. doi:
10.1111/ans.18049. Epub 2022 Sep 19.

6.

Hayashi M, Abe M, Fujita T, Matsushita H. Assessing the Prognostic Value of Extranodal
Extension in Esophageal Cancer from the Pathological Staging Perspective. J Invest Surg.
2022 Mar;35(3):698-706. doi: 10.1080/08941939.2021.1912221. Epub 2021 Jun 6.

7.

Hayashi M, Fujita T, Matsushita H. Prognostic value of tumor regression grade following
theadministrationofneoadjuvant

chemotherapy

astreatmentforgastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies. EurJ Surg Oncol. 2021 Aug;47(8):1996-2003. doi: 10.1016/j.ejso.2020.12.010. Epub 2020
Dec 19.
8.

Hayashi M, Fujita T, Matsushita H. Laparoscopic mediastinal approach for retrosternal
gastric conduit cancer after esophagectomy. Asian J Endosc Surg. 2021 Jul;14(3):582-

585. doi: 10.1111/ases.12895. Epub 2020 Nov 8.
9.

Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T.
Intraoperative blood loss as an independent prognostic factor for curative resection after
neoadjuvant chemotherapy for gastric cancer: a single-center retrospective cohort study.

Surg Today. 2021 Feb;51(2):293-302. doi: 10.1007/s00595-020-02114-3. Epub 2020
Aug 24.
10. Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T.
Predictive Value of the Surgical Apgar Score on Postoperative Complications in
Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Followedby Radical Gastrectomy: A Single-center Retrospective Study. BMC Surg. 2020 Jul
11;20(1):150. doi: 10.1186/s12893-020-00813-9.
11. Hayashi M, Takeuchi H, Nakamura R, Suda K, Wada N, Kawakubo H, Kitagawa Y.
Determination of the optimal surgical procedure by identifying risk factors forpneumonia after transthoracic esophagectomy. Esophagus. 2020 Jan;17(1):50-58. doi:
10.1007/s10388-019-00692-x. Epub 2019 Sep 9.
12. Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T.
Does neoadjuvant chemotherapy cancel out the negative survival impact induced bysurgical complications after gastrectomy? Gastric Cancer. 2019 Nov;22(6):1274-1284.
doi: 10.1007/s10120-019-00957-5. Epub 2019 Apr 3.
13. Hayashi M, Kawakubo H, Fukuda K, Mayanagi S, Nakamura R, Suda K, Hayashida T,Wada N, Kitagawa Y. THUMP domain containing 2 protein possibly induces resistanceto cisplatin and 5-fluorouracil in in vitro human esophageal squamous cell carcinoma
cells as revealed by transposon activation mutagenesis. J Gene Med. 2019 Dec;21(12).
doi: 10.1002/jgm.3135. Epub 2019 Dec 18.
14. Hayashi M, Kawakubo H, Mayanagi S, Nakamura R, Suda K, Wada N, Kitagawa Y. A low
surgical Apgar score is a predictor of anastomotic leakage after transthoracic
esophagectomy, but not a prognostic factor. Esophagus. 2019 Oct;16(4):386-394. doi:
10.1007/s10388-019-00678-9. Epub 2019 Jun 5.
15. Hayashi M, Kawakubo H, Shoji Y, Mayanagi S, Nakamura R, Suda K, Wada N, Takeuchi

H, Kitagawa Y. Analysis of the effect of early vs conventional nasogastric tube removal
on postoperative complications after transthoracic esophagectomy: A single-center,randomized

controlled

trial.

WorldJSurg.

2019

Feb;43(2):580-589.

doi:

10.1007/s00268-018-4825-1.
16. Hayashi M, Kawakubo H, Mayanagi S, Nakamura R, Suda K, Wada N, Kitagawa Y.
Gastric inflammatory myofibroblastic tumor treated with combined laparoscopic andendoscopic gastric wedge resection: a case report. World J Surg Oncol. 2018 Aug
8;16(1):161. doi: 10.1186/s12957-018-1460-0.